Dianthus Therapeutics, Inc. (DNTH)

NASDAQ: DNTH · Real-Time Price · USD

89.77

-1.89 (-2.06%)

At close: Apr 10, 2026, 4:00 PM EDT

89.88

+0.11 (0.12%)

After-hours: Apr 10, 2026, 7:42 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Biotechnology (Startups)	2.04M	6.24M	2.83M	6.42M	1.48M
Biotechnology (Startups) Growth	-67.35%	120.63%	-55.96%	334.76%	-
Total	2.04M	6.24M	2.83M	6.42M	1.48M
Total Growth	-67.35%	120.63%	-55.96%	334.76%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	2.04M	6.24M	2.83M	6.42M	1.48M
United States Growth	-67.35%	120.63%	-55.96%	334.76%	-
Total	2.04M	6.24M	2.83M	6.42M	1.48M
Total Growth	-67.35%	120.63%	-55.96%	334.76%	-

Source: S&P Global Market Intelligence.